One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Definitions of Histological Abnormalities in Inflammatory Bowel Disease: an ECCO Position Paper
doi : 10.1093/ecco-jcc/jjad142
Volume 18, Issue 2, February 2024
Thiopurines Have Sustained Long-term Effectiveness in Patients with Inflammatory Bowel Disease, Which is Independent of Disease Duration at Initiation: A Propensity Score Matched Analysis
doi : 10.1093/ecco-jcc/jjad135
Race and Ethnic Representation in Crohn’s Disease Trials of Biologic and Small Molecule Medications: A Systematic Review and Meta-analysis
doi : 10.1093/ecco-jcc/jjad138
Adalimumab Clearance, Rather Than Trough Level, May Have Greatest Relevance to Crohn’s Disease Therapeutic Outcomes Assessed Clinically and Endoscopically
doi : 10.1093/ecco-jcc/jjad140
Transcriptomic Profiling and Cellular Composition of Creeping Fat in Crohn’s disease
doi : 10.1093/ecco-jcc/jjad141
Outcomes Following Acute Severe Colitis at Initial Presentation: A Multi-centre, Prospective, Paediatric Cohort Study
doi : 10.1093/ecco-jcc/jjad143
Disease Activity Patterns of Paediatric Inflammatory Bowel Disease: A Danish Nationwide Cohort Study (1996–2018)
doi : 10.1093/ecco-jcc/jjad144
Short-term Psychodynamic Psychotherapy in Addition to Standard Medical Therapy Increases Clinical Remission in Adolescents and Young Adults with Inflammatory Bowel Disease: a Randomised Controlled Trial
doi : 10.1093/ecco-jcc/jjad145
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension
doi : 10.1093/ecco-jcc/jjad146
Validation of the IBD-Control Questionnaire across different sociodemographic and clinical subgroups: secondary analysis of a nationwide electronic survey
doi : 10.1093/ecco-jcc/jjad147
Validation of the ACE [Albumin, CRP, and Endoscopy] Index in Acute Colitis: Analysis of the CONSTRUCT dataset
doi : 10.1093/ecco-jcc/jjad148
Superior predictive value of transmural over endoscopic severity for colectomy risk in ulcerative colitis: a multicentre prospective cohort study
doi : 10.1093/ecco-jcc/jjad152
Tofacitinib Versus Oral Prednisolone for Induction of Remission in Moderately Active Ulcerative Colitis [ORCHID]: A Prospective, Open-Label, Randomized, Pilot Study
doi : 10.1093/ecco-jcc/jjad153
The Incidence and Prevalence of Inflammatory Bowel Disease Continues to Increase in the Faroe Islands – A Cohort Study from 1960 to 2020
doi : 10.1093/ecco-jcc/jjad155
The Diagnostic Utility of Volatile Organic Compounds in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
doi : 10.1093/ecco-jcc/jjad132
Lémman Index in Paediatric Crohn’s disease—Evidence Is Accumulating
doi : 10.1093/ecco-jcc/jjad161
Corrigendum to: Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial
doi : 10.1093/ecco-jcc/jjad136
